News & Events about Biolife Solutions Inc.
LEXINGTON, Mass., Jan. 26, 2023 (GLOBE NEWSWIRE) -- iVexSol Inc., a technology-based lentiviral vector (LVV) contract development and manufacturing organization (CDMO), announced $23.8 million in Series A-3 funding. New investors Bristol Myers Squibb (NYSE: BMY), Charles River Laboratories (NYSE: ...
BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023 BioLife Solutions to Announce Preliminary 2022 Revenue and Introduce 2023 Revenue Guidance on January 9, 2023 PR Newswire BOTHELL, Wash., Dec. 19, 2022 Announcement Precedes Meetings to be...
BioLife Solutions Expands Intellectual Property Estate BioLife Solutions Expands Intellectual Property Estate PR Newswire BOTHELL, Wash., Nov. 21, 2022 7 New Granted Patents; 43 Submitted Patent Applications Global Portfolio Now Totals 148 Issued and 114 Pending Patents BOTHELL, Wash., Nov. 21...
BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors BioLife Solutions Appoints Cell Therapy Executive Timothy L. Moore to its Board of Directors PR Newswire BOTHELL, Wash., Aug. 25, 2022 Industry veteran brings extensive technical operations scale-up...
Ticker Report
6 months ago
New York State Common Retirement Fund grew its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS Get Rating) by 6.5% during the first quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The institutional investor owned 191,555 ...